NASDAQ:SLGL

Sol-Gel Technologies Q3 2025 Earnings Results & Report

Sol-Gel Technologies logo
$52.83 -2.13 (-3.88%)
Closing price 04:00 PM Eastern
Extended Trading
$52.56 -0.27 (-0.51%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sol-Gel Technologies missed analyst earnings expectations but beat on revenue in its Q3 2025 results, released November 20, 2025. The company reported EPS of -$2.13 versus the -$2.09 consensus estimate, while revenue of $400 thousand topped the $300 thousand estimate by $100.00 thousand.

Earnings Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call
8:30 AM ET

Sol-Gel Technologies EPS Results

Actual EPS
-$2.13
Consensus EPS
-$2.09
Beat/Miss
Missed by -$0.04
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 8 quarters

Sol-Gel Technologies Revenue Results

Actual Revenue
$400 thousand
Expected Revenue
$300 thousand
Beat/Miss
Beat by +$100.00 thousand
YoY Revenue Growth
N/A

Earnings Documents

Sol-Gel Technologies Q3 2025 Earnings FAQ

Sol-Gel Technologies (NASDAQ:SLGL) reported earnings of -$2.13 per share for Q3 2025, missing the consensus estimate of -$2.09. The report was announced on Thursday, November 20, 2025.

Sol-Gel Technologies reported revenue of $400 thousand for Q3 2025, against a consensus estimate of $300 thousand.

Sol-Gel Technologies Earnings Headlines

Contrasting Sol-Gel Technologies (SLGL) & Its Rivals
The next convergence is here
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
Sol-Gel Technologies (SLGL) Projected to Release Earnings on Thursday
See More Sol-Gel Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sol-Gel Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sol-Gel Technologies and other key companies, straight to your email.

About Sol-Gel Technologies

Sol-Gel Technologies (NASDAQ:SLGL) is an Israel-based dermatology company that develops topical treatments for skin conditions. Its proprietary technology uses silica-based microencapsulation to formulate active ingredients for topical use.

The company’s products include Epsolay, a benzoyl peroxide cream approved in the United States for inflammatory lesions of rosacea, and Twyneo, a topical combination of tretinoin and benzoyl peroxide approved for acne vulgaris.

Sol-Gel has pursued commercialization and licensing opportunities in the United States and other markets. Its business also includes developing additional dermatology treatments using its formulation platform.

View Sol-Gel Technologies Profile